LIQUISOLID COMPACTS: A NOVEL APPROACH TO ENHANCE BIOAVAILABILITY OF POORLY SOLUBLE DRUGS

摘要

At present 40% of the drugs in the development pipelines, and approximately 60 % of the drugs coming directly from synthesis are poorly soluble. The limited solubility of drugs is a challenging issue for industry, during the development of the ideal solid